m2163是一帶正電抗菌胜肽，由實驗室發表文獻已知其可抑制數種乳酸菌及李斯特菌的生長，且對大腸癌細胞SW480也有生長抑制及細胞凋亡的現象，但其造成SW480生長受抑制與細胞凋亡的原因尚不清楚，本實驗希望能找出m2163與SW480之間的作用機制，透過螢光標定m2163及流式細胞儀的偵測，證實m2163可與SW480結合，經螢光顯微鏡和共軛焦顯微鏡觀察到m2163乃作用於SW480細胞膜，由於文獻指出部分造成癌細胞細胞凋亡的抗菌胜肽是作用在粒線體，於是進一步將粒線體純化，但並沒有在粒線體偵測到m2163，推測粒線體並非m2163的作用位置，此外也針對細胞膜通透性加以分析，發現m2163會破壞細胞膜完整性，且發生在細胞凋亡之前，推論m2163透過作用於細胞膜並破壞細胞膜完整性，後續造成細胞生長受到抑制以及誘發細胞凋亡。

m2163 is a cationic antimicrobial peptide that inhibits SW480 cells proliferation and induces apoptosis. However, the process by which m2163 kills SW480 cells is not well understood. This study shows that apoptosis and proliferation inhibition in SW480 cells were precedes by m2163 binding to, and progressive permeabilization of the cell membrane. Flow cytometry reveals that m2163 interacts with SW480 cells. In addition, fluorescent microscopy and confocal microscopy show that m2163 localizes with cell membrane in SW480 cells. Mitochondria may not the target of m2163 because purified mitochondria which isolated after treated with FITC-m2163 were not detected fluorescent signal by flow cytometry. Furthermore, m2163 disrupts SW480 cell membrane integrity prior to apoptosis induction. These data suggest that interaction mechanism between m2163 and SW480 cells results from localization with and permeabilization of the cell membrane.

Chen, L., N. Patrone and J. F. Liang (2012). "Peptide self-assembly on cell membranes to induce cell lysis." Biomacromolecules 13(10): 3327-3333.
Cornut, G., C. Fortin and D. Soulieres (2008). "Antineoplastic properties of bacteriocins: revisiting potential active agents." Am J Clin Oncol 31(4): 399-404.
Cotter, P. D., C. Hill and R. P. Ross (2005). "Bacteriocins: developing innate immunity for food." Nat Rev Microbiol 3(10): 777-788.
Havarstein, L. S., D. B. Diep and I. F. Nes (1995). "A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export." Mol Microbiol 16(2): 229-240.
Horton, K. L. and S. O. Kelley (2009). "Engineered apoptosis-inducing peptides with enhanced mitochondrial localization and potency." J Med Chem 52(10): 3293-3299.
Hoskin, D. W. and A. Ramamoorthy (2008). "Studies on anticancer activities of antimicrobial peptides." Biochim Biophys Acta 1778(2): 357-375.
Kuo, Y. C., C. F. Liu, J. F. Lin, A. C. Li, T. C. Lo and T. H. Lin (2013). "Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334." Appl Microbiol Biotechnol 97(1): 237-246.
Mader, J. S., A. Richardson, J. Salsman, D. Top, R. de Antueno, R. Duncan and D. W. Hoskin (2007). "Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria." Exp Cell Res 313(12): 2634-2650.
Nguyen, L. T., E. F. Haney and H. J. Vogel (2011). "The expanding scope of antimicrobial peptide structures and their modes of action." Trends Biotechnol 29(9): 464-472.
Nissen-Meyer, J., P. Rogne, C. Oppegard, H. S. Haugen and P. E. Kristiansen (2009). "Structure-function relationships of the non-lanthionine-containing peptide (class II) bacteriocins produced by gram-positive bacteria." Curr Pharm Biotechnol 10(1): 19-37.
Ohara, K., T. Horibe, M. Kohno and K. Kawakami (2011). "Characterization of antilytic peptide antibody: application for the detection of lytic-based hybrid peptide in serum samples." J Pept Sci 17(7): 493-498.
Papo, N., D. Seger, A. Makovitzki, V. Kalchenko, Z. Eshhar, H. Degani and Y. Shai (2006). "Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide." Cancer Res 66(10): 5371-5378.
Perera, Y., H. G. Farina, J. Gil, A. Rodriguez, F. Benavent, L. Castellanos, R. E. Gomez, B. E. Acevedo, D. F. Alonso and S. E. Perea (2009). "Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity." Mol Cancer Ther 8(5): 1189-1196.
Richard, C., D. Drider, K. Elmorjani, D. Marion and H. Prevost (2004). "Heterologous expression and purification of active divercin V41, a class IIa bacteriocin encoded by a synthetic gene in Escherichia coli." J Bacteriol 186(13): 4276-4284.
Riedl, S., D. Zweytick and K. Lohner (2011). "Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs." Chem Phys Lipids 164(8): 766-781.
Riley, M. A. and J. E. Wertz (2002). "Bacteriocins: evolution, ecology, and application." Annu Rev Microbiol 56: 117-137.
Sand, S. L., T. M. Haug, J. Nissen-Meyer and O. Sand (2007). "The bacterial peptide pheromone plantaricin A permeabilizes cancerous, but not normal, rat pituitary cells and differentiates between the outer and inner membrane leaflet." J Membr Biol 216(2-3): 61-71.
Sand, S. L., J. Nissen-Meyer, O. Sand and T. M. Haug (2013). "Plantaricin A, a cationic peptide produced by Lactobacillus plantarum, permeabilizes eukaryotic cell membranes by a mechanism dependent on negative surface charge linked to glycosylated membrane proteins." Biochim Biophys Acta 1828(2): 249-259.
Sand, S. L., C. Oppegard, S. Ohara, T. Iijima, S. Naderi, H. K. Blomhoff, J. Nissen-Meyer and O. Sand (2010). "Plantaricin A, a peptide pheromone produced by Lactobacillus plantarum, permeabilizes the cell membrane of both normal and cancerous lymphocytes and neuronal cells." Peptides 31(7): 1237-1244.
Sookraj, K. A., W. B. Bowne, V. Adler, E. Sarafraz-Yazdi, J. Michl and M. R. Pincus (2010). "The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide." Cancer Chemother Pharmacol 66(2): 325-331.
Wu, J. M., P. S. Jan, H. C. Yu, H. Y. Haung, H. J. Fang, Y. I. Chang, J. W. Cheng and H. M. Chen (2009). "Structure and function of a custom anticancer peptide, CB1a." Peptides 30(5): 839-848.